Friedrich von Bohlen has been active in the Life Sciences since the beginning of his advanced education. He brings more than 20 years of entrepreneurial experience to the industry.
Together with Dietmar Hopp and Christof Hettich, he co-founded dievini in 2005. Since then, he has held the role of managing director of dievini. He also serves as the chairman or as a board member of companies which are a part of the dievini portfolio.
Friedrich von Bohlen began his professional career in 1992 as a project manager in research & development at Fresenius AG, Bad Homburg, following which he was assistant to the chairman of the supervisory board of FAG Kugelfischer KGaA,Schweinfurt. He then served as CEO of Wasag Chemie AG, Essen. In 1997 he co-founded Lion Bioscience AG, Heidelberg. He remained CEO of LION until the end of 2003 and has been Chairman of board since 2004.
Friedrich von Bohlen holds a Diploma in biochemistry from the University of Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology.